Thymostimulin in Advanced Hepatocellular Carcinoma: A Phase II Trial

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-8-72
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Clinical Phase II Study of Sorafenib in Advanced Hepatocellular Carcinoma

Anaplastology
2012English

Phase II Trial of Fenretinide in Advanced Renal Carcinoma

Investigational New Drugs
OncologyPharmacology
2005English

A Phase II Study of Cixutumumab (IMC-A12, NSC742460) in Advanced Hepatocellular Carcinoma

Journal of Hepatology
Hepatology
2014English

A Phase II Study of Paclitaxel in Advanced Bronchioloalveolar Carcinoma (EORTC Trial 08956)

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2005English

Gemcitabine Plus Carboplatin in Patients With Advanced Hepatocellular Carcinoma: Results of a Phase II Study

ISRN Oncology
2012English

Sorafenib With or Without Concurrent Transarterial Chemoembolization in Patients With Advanced Hepatocellular Carcinoma: A Phase III STAH Trial

Journal of Hepatology
Hepatology
2019English

A Phase II Trial of Gemcitabine Plus Carboplatin in Advanced Transitional Cell Carcinoma of the Urothelium

BMC Cancer
Cancer ResearchOncologyGenetics
2007English

Randomized, Phase II Trial of Sequential Hepatic Arterial Infusion Chemotherapy and Sorafenib Versus Sorafenib Alone as Initial Therapy for Advanced Hepatocellular Carcinoma: SCOOP-2 Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Gemcitabine Plus Vinorelbine as First-Line Chemotherapy in Advanced Nonsmall Cell Lung Carcinoma a Phase II Trial

Cancer
Cancer ResearchOncology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy